NEXT Pharma Summit ’s Post

In May, during the 2nd Omnichannel Conference by UBIQ events in Lisbon, Yuliya Sotska, Chief Brand and Communications Officer at Viseven, had the pleasure of interviewing David Schofield, CEO & Co-Founder of Fluence World, on the topic of AI. In just three answers to three questions, David shared several insights into AI in general and its specific applications in the pharmaceutical industry. ☑️ What does AI hold for the present and future? ☑️ How can we measure things that aren't number-based, and what is AI's role in terms of measurements and KPIs? ☑️ What is the strategy for AI implementation, especially in the pharmaceutical industry? Hit “play” and hear exclusive AI insights in this 4-minute conversation ⬇️

#Pharma commercial and #MedicalAffairs teams... curious about the future of market insights? 🤔 Ready to harness the power of #AI for real-time intelligence? Join us on May 8 with Reuters Events Pharma and expert panelists - Within3 CEO Lance Hill, Neeraj Goel Mittal of GSK, Nathan Lear of AstraZeneca, and Carlos Eid of Novartis for a discussion on the potential of AI in market behavior analysis and HCP insights. Key Topics: 1️⃣ Importance of market behavior analysis 2️⃣ How leading companies are integrating diverse data sources for comprehensive insights 3️⃣ Implementing market behavior analysis framework Reserve your spot today: https://hubs.la/Q02tYhMv0 #webinar #ReutersEvents

The McKinsey Global Institute (MGI) estimates that AI technologies could generate between $60 billion and $110 billion annually for the pharmaceutical and medical-product industries. At Clinakos Inc., we harness the power of Integrated Patient Data™ and Medically Smart AI™ to deliver real-time insights that drive smarter, faster decisions in life sciences. Our platform builds 360-degree patient profiles from thousands of data sources, uncovering patterns, and unmet needs, and enabling precise, targeted treatments. Here’s how we help you succeed: 🌟 New Product Launches: Accelerate time to market with precise patient targeting and smoother regulatory approvals. 🌟 Reducing Patient Drop-Offs: Improve adherence through personalized engagement strategies and data analytics. 🌟 Understanding Patient Journeys: Gain a complete view of patient journeys to develop more personalized interventions. 🌟 Open Data Questions: Seamlessly integrate structured and unstructured data to answer key questions. 🌟 Smart Patient Panels & Registries: Access niche populations in rare diseases and oncology for focused research. 🚀 Ready to take your product launch to new heights? DM us today to explore how Clinakos can transform your strategy and drive better patient outcomes! #LifeSciences #pharmaceuticals #healthcareai

📈 "To be good at AI, you have to be great at data." - Greg Meyers Today's episode of #Technovation features a panel from our most recent #MetisStrategySymposium with AstraZeneca CDO/CIO Cindy Hoots (she, her), Bristol Myers Squibb CDTO Greg Meyers, and Eli Lilly and Company CIDO Diogo Rau discussing with Peter High the profound impact of artificial intelligence on talent management, research and development, and operational efficiencies within the pharma and healthcare industry. Tune in to hear these executives share their insights on: 🧪 Discover how AI is revolutionizing clinical trials, making them more efficient and accurate, ultimately speeding up the development of life-saving treatments. 💡 Learn about the innovative ways AI is being used to attract, manage, and develop talent within the pharma industry, ensuring the right skills are in place to drive future innovations. 🏥 Hear how AI is improving internal workflows and customer service, from automating routine tasks to providing personalized patient care, enhancing overall operational efficiency. 🎧 Listen to the full interview here: https://lnkd.in/gGhRQQhg #DigitalTransformation #AI #ArtificialIntelligence #Pharma #Healthcare #podcast #podcastinterview #TechnovationPodcast

As commercial leaders in the dynamic #pharma and #biopharma sectors, we are consistently on the hunt for transformative insights. Today, I want to spotlight an article by PwC addressing the critical trends shaping our industry: https://hubs.li/Q02zr5R20 In the face of sustained competition, the article echoes what we at Performance Development Group emphasize: innovation is not just about breakthroughs, it’s about value creation. As we forge ahead, consider these pivotal moves: • Rethink Innovation: It's time to align our R&D compass with market needs while enhancing patient outcomes. • Leverage AI and Analytics: Accelerating the use of analytics and AI can redefine our productivity and speed to market, but don’t forget the human element, which is required to make it more meaningful and effective. • Transact to Transform: M&A offers growth opportunity, but consider how best to leverage collaboration and this partnership to enhance performance. #PharmaLeadership #InnovationStrategy #BusinessTransformation

Many industries and verticals will benefit from the transformation to the era of AI. With the capabilities and doing things smarter, more reliable, faster and accurate, the Healthcare vertical is primed to allow technology to determine the pace of chartering new horizons and finding cures and treatments that were never thought of before. To help pave the way, Genpact has stood tall and invested to enable this transformation and allow our clients and the healthcare vertical to grow at the speed it needs, and its patients are demanding. Take a look at #Genpact's insights from this years PMSA event. #Data #GenAI #Transformation #Healthcare #SolutionsThatSolveProblems

When leveraged strategically, AI becomes a useful tool for streamlining the commercialization of therapies and technologies. Download the article to learn how AI can be used across the product lifecycle from HEOR and medical affairs to and omnichannel marketing. Learn more: https://bit.ly/4a9ADnp #AIinDrugCommercialization #AIinHealthcare  #AvalereHealth #ArtificialIntelligence

When leveraged strategically, AI becomes a useful tool for streamlining the commercialization of therapies and technologies. Download the article to learn how AI can be used across the product lifecycle from HEOR and medical affairs to and omnichannel marketing. Learn more: https://bit.ly/4a9ADnp #AIinDrugCommercialization #AIinHealthcare  #AvalereHealth #ArtificialIntelligence

📢 Missed our webinar? 📢 No worries! You can now watch the recording of our insightful session on the Digital Target Operating Model in the Pharma Industry. 🎥 Watch it here: https://lnkd.in/djsgbWMx To see the recording make sure you are signed in with your Guest or Reply Account. Hosted by industry experts Andreas Steberl and Rainer Herzog, the session covered: 🔹 Patient engagement and insights 🔹 Evaluating engagement activities 🔹 Using digital health and AI effectively Don’t miss out on these valuable insights! #DigitalTransformation #AI #Pharma #Webinar

Hello folks, I’m excited to announce that I’ll be speaking at the AI for Pharma & Healthcare Summit, taking place from September 24th to 26th, 2024, at the Amsterdam Marriott Hotel. Join me and other industry leaders as we explore real-world applications of AI across the entire pharmaceutical value chain.   Download the full event agenda for more information: https://bit.ly/45N5qVw   The conference will focus on the following areas: AI as a Practical Tool: Dive deep into the nuts and bolts of implementing AI in Pharma, from overcoming data-sharing hurdles to justifying costs. Revolutionising Drug Design: Explore how AI is accelerating drug discovery. Optimising Clinical Trials: Discover how AI can streamline trials and improve data analysis. Transforming the Supply Chain: Witness how AI is revolutionising logistics to ensure timely and efficient drug delivery. Join me in Amsterdam, and together let’s unlock the full potential of AI and revolutionise the future of healthcare.